Use of venous thromboembolism prophylaxis in hospitalized patients
File version
Author(s)
Conlon, A
Chopra, V
Flanders, SA
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
National guidelines1 recommend objective risk stratification for venous thromboembolism (VTE) in hospitalized medical patients. The Padua Prediction Score risk assessment model2 is recommended to categorize patients as high or low risk. The Michigan Hospital Medicine Safety Consortium (HMS), a statewide quality collaborative aimed at preventing adverse events in hospitalized medical patients, collects detailed data on VTE risk factors, prophylactic treatment, and outcomes. Using data from the HMS,3 we sought to determine whether patients in this cohort were receiving appropriate VTE prophylaxis.
Journal Title
JAMA Internal Medicine
Conference Title
Book Title
Edition
Volume
178
Issue
8
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Ophthalmology and optometry
Persistent link to this record
Citation
Grant, PJ; Conlon, A; Chopra, V; Flanders, SA, Use of venous thromboembolism prophylaxis in hospitalized patients, JAMA Internal Medicine, 2018, 178 (8), pp. 1122-1124